Kantarci OH - Search Results

1

Novel immunomodulatory approaches for the management of multiple sclerosis.

Kantarci OH, Pirko I, Rodriguez M. Kantarci OH, et al. Clin Pharmacol Ther. 2014 Jan;95(1):32-44. doi: 10.1038/clpt.2013.196. Epub 2013 Oct 30. Clin Pharmacol Ther. 2014. PMID: 24173041 Review.

2

Identifying disease modifying genes in multiple sclerosis.

Kantarci OH, de Andrade M, Weinshenker BG. Kantarci OH, et al. J Neuroimmunol. 2002 Feb;123(1-2):144-59. doi: 10.1016/s0165-5728(01)00481-7. J Neuroimmunol. 2002. PMID: 11880159 Review.

3

Association of APOE polymorphisms with disease severity in MS is limited to women.

Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, De Andrade M, McMurray CT, Rodriguez M, Weinshenker BG. Kantarci OH, et al. Neurology. 2004 Mar 9;62(5):811-4. doi: 10.1212/01.wnl.0000113721.83287.83. Neurology. 2004. PMID: 15007140

4

Natural history of multiple sclerosis.

Kantarci OH, Weinshenker BG. Kantarci OH, et al. Neurol Clin. 2005 Feb;23(1):17-38, v. doi: 10.1016/j.ncl.2004.10.002. Neurol Clin. 2005. PMID: 15661086 Review. No abstract available.

5

Epidemiology and natural history of multiple sclerosis: new insights.

Kantarci O, Wingerchuk D. Kantarci O, et al. Curr Opin Neurol. 2006 Jun;19(3):248-54. doi: 10.1097/01.wco.0000227033.47458.82. Curr Opin Neurol. 2006. PMID: 16702830 Review.

6

Genetics and natural history of multiple sclerosis.

Kantarci OH. Kantarci OH. Semin Neurol. 2008 Feb;28(1):7-16. doi: 10.1055/s-2007-1019125. Semin Neurol. 2008. PMID: 18256983 Review.

7

A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.

Tutuncu M, Demirci NO, Özer F, Saip S, Kantarci OH, Siva A. Tutuncu M, et al. Among authors: kantarci oh. Mult Scler. 2011 Oct;17(10):1262-4. doi: 10.1177/1352458510387183. Epub 2010 Dec 6. Mult Scler. 2011. PMID: 21135019

8

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Tutuncu M, et al. Among authors: kantarci oh. Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26. Mult Scler. 2013. PMID: 22736750 Free PMC article.

9

Treatment of primary progressive multiple sclerosis.

Kantarci O. Kantarci O. Semin Neurol. 2013 Feb;33(1):74-8. doi: 10.1055/s-0033-1343798. Epub 2013 May 25. Semin Neurol. 2013. PMID: 23709215 Review.

10

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

De Felice KM, Novotna M, Enders FT, Faubion WA, Tremaine WJ, Kantarci OH, Raffals LE. De Felice KM, et al. Among authors: kantarci oh. Aliment Pharmacol Ther. 2015 Jan;41(1):99-107. doi: 10.1111/apt.12997. Epub 2014 Oct 27. Aliment Pharmacol Ther. 2015. PMID: 25348720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters